Cargando…
Prospects for Anti-Biofilm Pharmaceuticals
This commentary highlights several avenues currently being pursued in research labs to the development of new anti-biofilm pharmaceuticals. There is a real need for alternative therapeutic modalities for treating the persistent infections that sometimes form on implanted medical devices or compromis...
Autor principal: | Stewart, Philip S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588180/ https://www.ncbi.nlm.nih.gov/pubmed/26343685 http://dx.doi.org/10.3390/ph8030504 |
Ejemplares similares
-
The Pharmaceutical Sciences in 2020: Report of a Conference Organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP)
por: Shah, Vinod P., et al.
Publicado: (2010) -
Pharmaceutical Policy Part 2 Pharmaceutical engagement and policy development: a framework for influence
por: Morrow, Norman C
Publicado: (2015) -
The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010) -
Myxobacteria: natural pharmaceutical factories
por: Diez, Juana, et al.
Publicado: (2012) -
The Impact of Brexit on Pharmaceuticals and HTA
por: Lorgelly, Paula K
Publicado: (2018)